Retatrutide is a new weight loss treatment that targets multiple hormone pathways related to weight regulation
Opt for bland, easily digestible foods like crackers, toast, plain rice, bananas, and applesauce
Simcere Simcere recently (Jan 2025) made a deal with Abbvie for SIM0500, a GPRC5D/BCMA/CD33 trispecific antibody, currently in Phase 1 clinical trials in patients with relapsed or refractory multiple myeloma (MM), in both China and the U.S
Most people reach their target dose within 16 to 20 weeks, though some continue adjusting based on their response
10.13457/j.cnki.jncm.2021.17.003 191 YangJ.ZhangW.LinB.MaoS.LiuG.TanK.et al (2024)
While the benefits of tPA treatment greatly outweigh the risks of bleeding the question remains if this risk can be further reduced